Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
More than 250 clinicians signed a letter (PDF) to the Senate HELP Committee expressing concern about the lack of patient access to novel non-insulin diabetes and weight loss medications due to exorbitant prices set by manufacturers
GLP-1 as a regulator of sepsis outcomes: insights into cellular metabolism, inflammation, and therapeutic potential
The proven benefits beyond glucose control are expanding the use of GLP-1 receptor agonists and driving market growth
It was approved more recently for weight management and is based on a hormone that affects appetite and insulin regulation
US$ 24.71
US$ 24.57
US$ 20.43
US$ 25.70
US$ 26.98
US$ 21.61
US$ 29.59
US$ 24.42
